290 related articles for article (PubMed ID: 22492998)
1. Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease.
Tang B; Becanovic K; Desplats PA; Spencer B; Hill AM; Connolly C; Masliah E; Leavitt BR; Thomas EA
Hum Mol Genet; 2012 Jul; 21(14):3097-111. PubMed ID: 22492998
[TBL] [Abstract][Full Text] [Related]
2. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
[TBL] [Abstract][Full Text] [Related]
3. Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.
Desplats PA; Lambert JR; Thomas EA
Neurobiol Dis; 2008 Sep; 31(3):298-308. PubMed ID: 18595722
[TBL] [Abstract][Full Text] [Related]
4. FoxP1 orchestration of ASD-relevant signaling pathways in the striatum.
Araujo DJ; Anderson AG; Berto S; Runnels W; Harper M; Ammanuel S; Rieger MA; Huang HC; Rajkovich K; Loerwald KW; Dekker JD; Tucker HO; Dougherty JD; Gibson JR; Konopka G
Genes Dev; 2015 Oct; 29(20):2081-96. PubMed ID: 26494785
[TBL] [Abstract][Full Text] [Related]
5. Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop.
Kannike K; Sepp M; Zuccato C; Cattaneo E; Timmusk T
J Biol Chem; 2014 Nov; 289(47):32845-57. PubMed ID: 25271153
[TBL] [Abstract][Full Text] [Related]
6. FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis.
van Boxtel R; Gomez-Puerto C; Mokry M; Eijkelenboom A; van der Vos KE; Nieuwenhuis EE; Burgering BM; Lam EW; Coffer PJ
Cell Death Differ; 2013 Sep; 20(9):1219-29. PubMed ID: 23832113
[TBL] [Abstract][Full Text] [Related]
7. FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiation.
Precious SV; Kelly CM; Reddington AE; Vinh NN; Stickland RC; Pekarik V; Scherf C; Jeyasingham R; Glasbey J; Holeiter M; Jones L; Taylor MV; Rosser AE
Exp Neurol; 2016 Aug; 282():9-18. PubMed ID: 27154297
[TBL] [Abstract][Full Text] [Related]
8. Control of Huntington's Disease-Associated Phenotypes by the Striatum-Enriched Transcription Factor Foxp2.
Hachigian LJ; Carmona V; Fenster RJ; Kulicke R; Heilbut A; Sittler A; Pereira de Almeida L; Mesirov JP; Gao F; Kolaczyk ED; Heiman M
Cell Rep; 2017 Dec; 21(10):2688-2695. PubMed ID: 29212017
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1-Endothelin-1 Signal Pathway.
Liu J; Zhuang T; Pi J; Chen X; Zhang Q; Li Y; Wang H; Shen Y; Tomlinson B; Chan P; Yu Z; Cheng Y; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y
Circulation; 2019 Aug; 140(8):665-680. PubMed ID: 31177814
[TBL] [Abstract][Full Text] [Related]
10. Grb2 is regulated by foxd3 and has roles in preventing accumulation and aggregation of mutant huntingtin.
Baksi S; Jana NR; Bhattacharyya NP; Mukhopadhyay D
PLoS One; 2013; 8(10):e76792. PubMed ID: 24116161
[TBL] [Abstract][Full Text] [Related]
11. In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.
Thomas EA; Coppola G; Tang B; Kuhn A; Kim S; Geschwind DH; Brown TB; Luthi-Carter R; Ehrlich ME
Hum Mol Genet; 2011 Mar; 20(6):1049-60. PubMed ID: 21177255
[TBL] [Abstract][Full Text] [Related]
12. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.
Jiang M; Wang J; Fu J; Du L; Jeong H; West T; Xiang L; Peng Q; Hou Z; Cai H; Seredenina T; Arbez N; Zhu S; Sommers K; Qian J; Zhang J; Mori S; Yang XW; Tamashiro KL; Aja S; Moran TH; Luthi-Carter R; Martin B; Maudsley S; Mattson MP; Cichewicz RH; Ross CA; Holtzman DM; Krainc D; Duan W
Nat Med; 2011 Dec; 18(1):153-8. PubMed ID: 22179319
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.
Shi C; Miley J; Nottingham A; Morooka T; Prosdocimo DA; Simon DI
Biochim Biophys Acta Gene Regul Mech; 2019 Apr; 1862(4):493-508. PubMed ID: 30831269
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.
Niewiadomska-Cimicka A; Krzyżosiak A; Ye T; Podleśny-Drabiniok A; Dembélé D; Dollé P; Krężel W
Mol Neurobiol; 2017 Jul; 54(5):3859-3878. PubMed ID: 27405468
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
18. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.
Roze E; Betuing S; Deyts C; Marcon E; Brami-Cherrier K; Pagès C; Humbert S; Mérienne K; Caboche J
FASEB J; 2008 Apr; 22(4):1083-93. PubMed ID: 18029446
[TBL] [Abstract][Full Text] [Related]
19. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease.
Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM
Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958
[TBL] [Abstract][Full Text] [Related]
20. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease.
Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF
Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
